1. Home
  2. ONMD vs CRVO Comparison

ONMD vs CRVO Comparison

Compare ONMD & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.09

Market Cap

45.8M

Sector

N/A

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.92

Market Cap

37.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
CRVO
Founded
2006
2001
Country
United States
United States
Employees
23
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.8M
37.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
ONMD
CRVO
Price
$1.09
$3.92
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
263.7K
34.5K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$3.51
52 Week High
$4.22
$13.13

Technical Indicators

Market Signals
Indicator
ONMD
CRVO
Relative Strength Index (RSI) 68.48 42.86
Support Level $1.04 $3.55
Resistance Level $1.20 $4.41
Average True Range (ATR) 0.09 0.27
MACD 0.01 0.02
Stochastic Oscillator 67.35 27.51

Price Performance

Historical Comparison
ONMD
CRVO

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: